Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride does not prevent bladder cancer.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Oral testosterone therapy raises heart risk more than other methods.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Testosterone's effects on COVID-19 are unclear and need more research.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Phytoandrogens from plants may help treat low testosterone naturally.